Skip to content
10-Q

Quarterly Report

AMBIT BIOSCIENCES CORP

0001193125-13-432881

← back to feed
Filed
Nov 7, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 17.88M sh
Capex Q3 2013 · Sep 30, 2013 $568K
Capex Q3 2013 · Sep 30, 2012 $12K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$19.71M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$21.46M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $78.86M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $17.48M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $4.56M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $16.42M
Stockholders Equity Q3 2013 · Sep 30, 2013 $58.75M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$198.25M
Current Liabilities Q3 2013 · Sep 30, 2013 $22.02M
Current Liabilities Q3 2013 · Dec 31, 2012 $29.83M
Current Assets Q3 2013 · Sep 30, 2013 $79.89M
Current Assets Q3 2013 · Dec 31, 2012 $18.71M
Total Assets Q3 2013 · Sep 30, 2013 $80.77M
Total Assets Q3 2013 · Dec 31, 2012 $19.99M
Sga Expense Q3 2013 · Sep 30, 2013 $3.08M
Sga Expense Q3 2013 · Sep 30, 2013 $7.05M
Sga Expense Q3 2013 · Sep 30, 2012 $1.23M
Sga Expense Q3 2013 · Sep 30, 2012 $4.53M
Rd Expense Q3 2013 · Sep 30, 2013 $4.48M
Rd Expense Q3 2013 · Sep 30, 2013 $20.15M
Rd Expense Q3 2013 · Sep 30, 2012 $8.17M
Rd Expense Q3 2013 · Sep 30, 2012 $30.12M
Net Income Q3 2013 · Sep 30, 2013 −$6.07M
Net Income Q3 2013 · Sep 30, 2013 −$9.15M
Net Income Q3 2013 · Sep 30, 2012 −$6.58M
Net Income Q3 2013 · Sep 30, 2012 −$21.64M
Operating Income Q3 2013 · Sep 30, 2013 $2.62M
Operating Income Q3 2013 · Sep 30, 2013 $1.12M
Operating Income Q3 2013 · Sep 30, 2012 −$4.64M
Operating Income Q3 2013 · Sep 30, 2012 −$18.36M